Transition to Subcutaneous Infliximab vs Vedolizumab in Inflammatory Bowel Disease: A Prospective Multicenter Study
Digestive Diseases and Sciences · 2024
DOI: 10.1007/s10620-024-08631-2 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Digestive Diseases and Sciences, 2024. Verfasst von Mariabeatrice Principi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Unit, DiMePreJ, "Aldo Moro" University, Bari, Italy. b.principi@gmail.com. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Infliximab, Quality of Life, Gastrointestinal Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastroenterology Unit, DiMePreJ, "Aldo Moro" University, Bari, Italy. b.principi@gmail.com.
- P.O. Di Venere, UOSVD Screening Colon Retto Endoscopia Digestiva, Bari, Italy.
- Ospedale Vito Fazzi, UOS Gastroenterologia Ed Endoscopia Digestiva, Lecce, Italy.
- Ospedale Di Miccoli, UOC Gastroenterologia, Barletta, Italy.
- Department of Economics and Finance, University of Bari Aldo Moro, Bari, Italy.
- Gastroenterology Unit, DiMePreJ, "Aldo Moro" University, Bari, Italy.
Zitieren
APA
Principi, M., Brescia, I. V., Stasi, E., Mazzuoli, S., D'Uggento, A. M., Equatore, E., Lacavalla, I., & Di Leo, A. (2024). Transition to Subcutaneous Infliximab vs Vedolizumab in Inflammatory Bowel Disease: A Prospective Multicenter Study. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-024-08631-2
Vancouver
Principi M, Brescia IV, Stasi E, Mazzuoli S, D'Uggento AM, Equatore E, et al. Transition to Subcutaneous Infliximab vs Vedolizumab in Inflammatory Bowel Disease: A Prospective Multicenter Study. Digestive Diseases and Sciences. 2024. doi:10.1007/s10620-024-08631-2
BibTeX
@article{Principi2024,
author = {Principi, Mariabeatrice and Brescia, Irene Vita and Stasi, Elisa and Mazzuoli, Silvia and D'Uggento, Angela Maria and Equatore, Elena and Lacavalla, Ilaria and Di Leo, Alfredo},
title = {Transition to Subcutaneous Infliximab vs Vedolizumab in Inflammatory Bowel Disease: A Prospective Multicenter Study},
journal = {Digestive Diseases and Sciences},
year = {2024},
doi = {10.1007/s10620-024-08631-2}
}
EUVIMED